Loading…

Didecyldimethylammonium chloride-induced lung fibrosis may be associated with phospholipidosis

In the current study, we dosed didecyldimethylammonium chloride (DDAC) in mice by pharyngeal aspiration for 28 days or 90 days (weekly) and tried to elucidate the relationship between lamellar body formation and the lesions. When exposed for 28 days (0, 5, 10, 50, and 100 μg/head), all the mice in t...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology and applied pharmacology 2025-02, Vol.495, p.117211, Article 117211
Main Authors: Jung, Wonkyun, Yang, Mi-Jin, Kang, Min-Sung, Lim, Jiyun, Choi, Hyosun, Lee, Ji Ae, Yoon, Kyung-Sik, Kim, Jin-Bae, Park, Eun-Jung
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c1523-89646618eeee10d479900328d923856ef0ac6b90de5154bd02d114f45ede8d453
container_end_page
container_issue
container_start_page 117211
container_title Toxicology and applied pharmacology
container_volume 495
creator Jung, Wonkyun
Yang, Mi-Jin
Kang, Min-Sung
Lim, Jiyun
Choi, Hyosun
Lee, Ji Ae
Yoon, Kyung-Sik
Kim, Jin-Bae
Park, Eun-Jung
description In the current study, we dosed didecyldimethylammonium chloride (DDAC) in mice by pharyngeal aspiration for 28 days or 90 days (weekly) and tried to elucidate the relationship between lamellar body formation and the lesions. When exposed for 28 days (0, 5, 10, 50, and 100 μg/head), all the mice in the 50 and 100 μg/head groups died since Day 2 after the third dosing (Day 16 after the first dosing). Edema, necrosis of bronchiolar and alveolar epithelium, and fibrinous exudate were observed in the lungs of all the dead mice, and chronic inflammatory lesions were observed in the lung tissues of alive mice. When dosed with DDAC of 0, 1, 4, and 8 μg/head for 13 weeks, the total number of pulmonary cells and the pulmonary levels of pro- and anti-inflammatory cytokines significantly increased, and chronic inflammatory lesions were detected with the production of collagen, collagen fibers, and lamellar body-like structures. Swelling of the nuclear envelope and nucleoplasmic components and generation of lipid droplets were also notably observed in the lung tissues of DDAC (8 μg/head)-treated mice. Furthermore, transcriptomic analysis performed using human bronchial epithelial cells showed that DDAC affected the expression of DNA damage, ER stress, lipid metabolism, and transcription regulation-related genes at 6 h after treatment, as it did 24 h treatment and that early growth response factor 1 gene was added to a list of the most up-regulated genes. Meanwhile, cytokines that are associated with the pathology of chronic lung diseases (IL-11, IL-24, and TGF-β) were slightly increased in the lung of DDAC-treated mice, and only the pulmonary level of CCL-2, but not CXCL-1 and CCL-3, increased in both sexes of mice. More importantly, the GM-CSF level increased dose-dependently in the lungs of both sexes of mice exposed to DDAC. Considering that the wound-healing process can take several weeks to complete, we suggest that DDAC-induced pulmonary fibrosis may be attributable to disruption of the wound-healing process due to continuous exposure to DDAC. We also hypothesize that the formation of lamellar bodies may be attributable to lysosomal accumulation of phospholipids separated from the destroyed lung tissue membrane. •Repeated aspiration of DDAC (more than 50 μg/head) caused the sudden death of mice.•Lamellar bodies and lipid droplets were found in the lung tissues of the treated mice.•DDAC formed collagen fibers and caused interstitial fibrosis in the lungs of mice.•
doi_str_mv 10.1016/j.taap.2024.117211
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3148495166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X24004101</els_id><sourcerecordid>3148495166</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1523-89646618eeee10d479900328d923856ef0ac6b90de5154bd02d114f45ede8d453</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVpyW62-QM9FB9zsTNjyVoLcimbTwjk0kJOEbI07mrxVyy7Yf99tew2xw4Mc5hnXpiHsW8IGQLKq102GTNkOeQiQ1zniJ_YEkHJFDjnn9kSQGAKUL4s2HkIOwBQQuAZW3C1jgkFX7LXG-_I7hvnW5q2-8a0bd_5uU3stunHuEt952ZLLmnm7ndS-2rsgw9Ja_ZJRYkJobfeTHH_7qdtMmz7ELvxg3cH7iv7Upsm0MVprtivu9ufm4f06fn-cfPjKbVY5DwtlRRSYkmxEJxYKwXA89KpnJeFpBqMlZUCRwUWonKQO0RRi4IclU4UfMUuj7nD2L_NFCbd-mCpaUxH_Rw0R1EKVaCUEc2PqI2fhJFqPYy-NeNeI-iDV73TB6_64FUfvcaj76f8uWrJfZz8ExmB6yNA8cs_nkYdrKcuivMj2Um73v8v_y9k7YpH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3148495166</pqid></control><display><type>article</type><title>Didecyldimethylammonium chloride-induced lung fibrosis may be associated with phospholipidosis</title><source>ScienceDirect Freedom Collection</source><creator>Jung, Wonkyun ; Yang, Mi-Jin ; Kang, Min-Sung ; Lim, Jiyun ; Choi, Hyosun ; Lee, Ji Ae ; Yoon, Kyung-Sik ; Kim, Jin-Bae ; Park, Eun-Jung</creator><creatorcontrib>Jung, Wonkyun ; Yang, Mi-Jin ; Kang, Min-Sung ; Lim, Jiyun ; Choi, Hyosun ; Lee, Ji Ae ; Yoon, Kyung-Sik ; Kim, Jin-Bae ; Park, Eun-Jung</creatorcontrib><description>In the current study, we dosed didecyldimethylammonium chloride (DDAC) in mice by pharyngeal aspiration for 28 days or 90 days (weekly) and tried to elucidate the relationship between lamellar body formation and the lesions. When exposed for 28 days (0, 5, 10, 50, and 100 μg/head), all the mice in the 50 and 100 μg/head groups died since Day 2 after the third dosing (Day 16 after the first dosing). Edema, necrosis of bronchiolar and alveolar epithelium, and fibrinous exudate were observed in the lungs of all the dead mice, and chronic inflammatory lesions were observed in the lung tissues of alive mice. When dosed with DDAC of 0, 1, 4, and 8 μg/head for 13 weeks, the total number of pulmonary cells and the pulmonary levels of pro- and anti-inflammatory cytokines significantly increased, and chronic inflammatory lesions were detected with the production of collagen, collagen fibers, and lamellar body-like structures. Swelling of the nuclear envelope and nucleoplasmic components and generation of lipid droplets were also notably observed in the lung tissues of DDAC (8 μg/head)-treated mice. Furthermore, transcriptomic analysis performed using human bronchial epithelial cells showed that DDAC affected the expression of DNA damage, ER stress, lipid metabolism, and transcription regulation-related genes at 6 h after treatment, as it did 24 h treatment and that early growth response factor 1 gene was added to a list of the most up-regulated genes. Meanwhile, cytokines that are associated with the pathology of chronic lung diseases (IL-11, IL-24, and TGF-β) were slightly increased in the lung of DDAC-treated mice, and only the pulmonary level of CCL-2, but not CXCL-1 and CCL-3, increased in both sexes of mice. More importantly, the GM-CSF level increased dose-dependently in the lungs of both sexes of mice exposed to DDAC. Considering that the wound-healing process can take several weeks to complete, we suggest that DDAC-induced pulmonary fibrosis may be attributable to disruption of the wound-healing process due to continuous exposure to DDAC. We also hypothesize that the formation of lamellar bodies may be attributable to lysosomal accumulation of phospholipids separated from the destroyed lung tissue membrane. •Repeated aspiration of DDAC (more than 50 μg/head) caused the sudden death of mice.•Lamellar bodies and lipid droplets were found in the lung tissues of the treated mice.•DDAC formed collagen fibers and caused interstitial fibrosis in the lungs of mice.•The pulmonary levels of inflammatory cytokines increased following DDAC exposure.•The level of EGR1 and endothelin-1 genes was notably regulated in DDAC-treated cells. [Display omitted]</description><identifier>ISSN: 0041-008X</identifier><identifier>ISSN: 1096-0333</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2024.117211</identifier><identifier>PMID: 39710153</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Fibrosis ; Immune-suppression ; Lamellar bodies ; Lipid metabolism ; Phospholipidosis ; Quaternary ammonium compounds</subject><ispartof>Toxicology and applied pharmacology, 2025-02, Vol.495, p.117211, Article 117211</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1523-89646618eeee10d479900328d923856ef0ac6b90de5154bd02d114f45ede8d453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39710153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, Wonkyun</creatorcontrib><creatorcontrib>Yang, Mi-Jin</creatorcontrib><creatorcontrib>Kang, Min-Sung</creatorcontrib><creatorcontrib>Lim, Jiyun</creatorcontrib><creatorcontrib>Choi, Hyosun</creatorcontrib><creatorcontrib>Lee, Ji Ae</creatorcontrib><creatorcontrib>Yoon, Kyung-Sik</creatorcontrib><creatorcontrib>Kim, Jin-Bae</creatorcontrib><creatorcontrib>Park, Eun-Jung</creatorcontrib><title>Didecyldimethylammonium chloride-induced lung fibrosis may be associated with phospholipidosis</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>In the current study, we dosed didecyldimethylammonium chloride (DDAC) in mice by pharyngeal aspiration for 28 days or 90 days (weekly) and tried to elucidate the relationship between lamellar body formation and the lesions. When exposed for 28 days (0, 5, 10, 50, and 100 μg/head), all the mice in the 50 and 100 μg/head groups died since Day 2 after the third dosing (Day 16 after the first dosing). Edema, necrosis of bronchiolar and alveolar epithelium, and fibrinous exudate were observed in the lungs of all the dead mice, and chronic inflammatory lesions were observed in the lung tissues of alive mice. When dosed with DDAC of 0, 1, 4, and 8 μg/head for 13 weeks, the total number of pulmonary cells and the pulmonary levels of pro- and anti-inflammatory cytokines significantly increased, and chronic inflammatory lesions were detected with the production of collagen, collagen fibers, and lamellar body-like structures. Swelling of the nuclear envelope and nucleoplasmic components and generation of lipid droplets were also notably observed in the lung tissues of DDAC (8 μg/head)-treated mice. Furthermore, transcriptomic analysis performed using human bronchial epithelial cells showed that DDAC affected the expression of DNA damage, ER stress, lipid metabolism, and transcription regulation-related genes at 6 h after treatment, as it did 24 h treatment and that early growth response factor 1 gene was added to a list of the most up-regulated genes. Meanwhile, cytokines that are associated with the pathology of chronic lung diseases (IL-11, IL-24, and TGF-β) were slightly increased in the lung of DDAC-treated mice, and only the pulmonary level of CCL-2, but not CXCL-1 and CCL-3, increased in both sexes of mice. More importantly, the GM-CSF level increased dose-dependently in the lungs of both sexes of mice exposed to DDAC. Considering that the wound-healing process can take several weeks to complete, we suggest that DDAC-induced pulmonary fibrosis may be attributable to disruption of the wound-healing process due to continuous exposure to DDAC. We also hypothesize that the formation of lamellar bodies may be attributable to lysosomal accumulation of phospholipids separated from the destroyed lung tissue membrane. •Repeated aspiration of DDAC (more than 50 μg/head) caused the sudden death of mice.•Lamellar bodies and lipid droplets were found in the lung tissues of the treated mice.•DDAC formed collagen fibers and caused interstitial fibrosis in the lungs of mice.•The pulmonary levels of inflammatory cytokines increased following DDAC exposure.•The level of EGR1 and endothelin-1 genes was notably regulated in DDAC-treated cells. [Display omitted]</description><subject>Fibrosis</subject><subject>Immune-suppression</subject><subject>Lamellar bodies</subject><subject>Lipid metabolism</subject><subject>Phospholipidosis</subject><subject>Quaternary ammonium compounds</subject><issn>0041-008X</issn><issn>1096-0333</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNp9kE1r3DAQhkVpyW62-QM9FB9zsTNjyVoLcimbTwjk0kJOEbI07mrxVyy7Yf99tew2xw4Mc5hnXpiHsW8IGQLKq102GTNkOeQiQ1zniJ_YEkHJFDjnn9kSQGAKUL4s2HkIOwBQQuAZW3C1jgkFX7LXG-_I7hvnW5q2-8a0bd_5uU3stunHuEt952ZLLmnm7ndS-2rsgw9Ja_ZJRYkJobfeTHH_7qdtMmz7ELvxg3cH7iv7Upsm0MVprtivu9ufm4f06fn-cfPjKbVY5DwtlRRSYkmxEJxYKwXA89KpnJeFpBqMlZUCRwUWonKQO0RRi4IclU4UfMUuj7nD2L_NFCbd-mCpaUxH_Rw0R1EKVaCUEc2PqI2fhJFqPYy-NeNeI-iDV73TB6_64FUfvcaj76f8uWrJfZz8ExmB6yNA8cs_nkYdrKcuivMj2Um73v8v_y9k7YpH</recordid><startdate>202502</startdate><enddate>202502</enddate><creator>Jung, Wonkyun</creator><creator>Yang, Mi-Jin</creator><creator>Kang, Min-Sung</creator><creator>Lim, Jiyun</creator><creator>Choi, Hyosun</creator><creator>Lee, Ji Ae</creator><creator>Yoon, Kyung-Sik</creator><creator>Kim, Jin-Bae</creator><creator>Park, Eun-Jung</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202502</creationdate><title>Didecyldimethylammonium chloride-induced lung fibrosis may be associated with phospholipidosis</title><author>Jung, Wonkyun ; Yang, Mi-Jin ; Kang, Min-Sung ; Lim, Jiyun ; Choi, Hyosun ; Lee, Ji Ae ; Yoon, Kyung-Sik ; Kim, Jin-Bae ; Park, Eun-Jung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1523-89646618eeee10d479900328d923856ef0ac6b90de5154bd02d114f45ede8d453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Fibrosis</topic><topic>Immune-suppression</topic><topic>Lamellar bodies</topic><topic>Lipid metabolism</topic><topic>Phospholipidosis</topic><topic>Quaternary ammonium compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, Wonkyun</creatorcontrib><creatorcontrib>Yang, Mi-Jin</creatorcontrib><creatorcontrib>Kang, Min-Sung</creatorcontrib><creatorcontrib>Lim, Jiyun</creatorcontrib><creatorcontrib>Choi, Hyosun</creatorcontrib><creatorcontrib>Lee, Ji Ae</creatorcontrib><creatorcontrib>Yoon, Kyung-Sik</creatorcontrib><creatorcontrib>Kim, Jin-Bae</creatorcontrib><creatorcontrib>Park, Eun-Jung</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, Wonkyun</au><au>Yang, Mi-Jin</au><au>Kang, Min-Sung</au><au>Lim, Jiyun</au><au>Choi, Hyosun</au><au>Lee, Ji Ae</au><au>Yoon, Kyung-Sik</au><au>Kim, Jin-Bae</au><au>Park, Eun-Jung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Didecyldimethylammonium chloride-induced lung fibrosis may be associated with phospholipidosis</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2025-02</date><risdate>2025</risdate><volume>495</volume><spage>117211</spage><pages>117211-</pages><artnum>117211</artnum><issn>0041-008X</issn><issn>1096-0333</issn><eissn>1096-0333</eissn><abstract>In the current study, we dosed didecyldimethylammonium chloride (DDAC) in mice by pharyngeal aspiration for 28 days or 90 days (weekly) and tried to elucidate the relationship between lamellar body formation and the lesions. When exposed for 28 days (0, 5, 10, 50, and 100 μg/head), all the mice in the 50 and 100 μg/head groups died since Day 2 after the third dosing (Day 16 after the first dosing). Edema, necrosis of bronchiolar and alveolar epithelium, and fibrinous exudate were observed in the lungs of all the dead mice, and chronic inflammatory lesions were observed in the lung tissues of alive mice. When dosed with DDAC of 0, 1, 4, and 8 μg/head for 13 weeks, the total number of pulmonary cells and the pulmonary levels of pro- and anti-inflammatory cytokines significantly increased, and chronic inflammatory lesions were detected with the production of collagen, collagen fibers, and lamellar body-like structures. Swelling of the nuclear envelope and nucleoplasmic components and generation of lipid droplets were also notably observed in the lung tissues of DDAC (8 μg/head)-treated mice. Furthermore, transcriptomic analysis performed using human bronchial epithelial cells showed that DDAC affected the expression of DNA damage, ER stress, lipid metabolism, and transcription regulation-related genes at 6 h after treatment, as it did 24 h treatment and that early growth response factor 1 gene was added to a list of the most up-regulated genes. Meanwhile, cytokines that are associated with the pathology of chronic lung diseases (IL-11, IL-24, and TGF-β) were slightly increased in the lung of DDAC-treated mice, and only the pulmonary level of CCL-2, but not CXCL-1 and CCL-3, increased in both sexes of mice. More importantly, the GM-CSF level increased dose-dependently in the lungs of both sexes of mice exposed to DDAC. Considering that the wound-healing process can take several weeks to complete, we suggest that DDAC-induced pulmonary fibrosis may be attributable to disruption of the wound-healing process due to continuous exposure to DDAC. We also hypothesize that the formation of lamellar bodies may be attributable to lysosomal accumulation of phospholipids separated from the destroyed lung tissue membrane. •Repeated aspiration of DDAC (more than 50 μg/head) caused the sudden death of mice.•Lamellar bodies and lipid droplets were found in the lung tissues of the treated mice.•DDAC formed collagen fibers and caused interstitial fibrosis in the lungs of mice.•The pulmonary levels of inflammatory cytokines increased following DDAC exposure.•The level of EGR1 and endothelin-1 genes was notably regulated in DDAC-treated cells. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39710153</pmid><doi>10.1016/j.taap.2024.117211</doi></addata></record>
fulltext fulltext
identifier ISSN: 0041-008X
ispartof Toxicology and applied pharmacology, 2025-02, Vol.495, p.117211, Article 117211
issn 0041-008X
1096-0333
1096-0333
language eng
recordid cdi_proquest_miscellaneous_3148495166
source ScienceDirect Freedom Collection
subjects Fibrosis
Immune-suppression
Lamellar bodies
Lipid metabolism
Phospholipidosis
Quaternary ammonium compounds
title Didecyldimethylammonium chloride-induced lung fibrosis may be associated with phospholipidosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A04%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Didecyldimethylammonium%20chloride-induced%20lung%20fibrosis%20may%20be%20associated%20with%20phospholipidosis&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Jung,%20Wonkyun&rft.date=2025-02&rft.volume=495&rft.spage=117211&rft.pages=117211-&rft.artnum=117211&rft.issn=0041-008X&rft.eissn=1096-0333&rft_id=info:doi/10.1016/j.taap.2024.117211&rft_dat=%3Cproquest_cross%3E3148495166%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1523-89646618eeee10d479900328d923856ef0ac6b90de5154bd02d114f45ede8d453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3148495166&rft_id=info:pmid/39710153&rfr_iscdi=true